Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Cellular Oncology (Dordrecht, Netherlands)|October 27, 2018
Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - a short reportEkjot Kaur, Jayant S Goda, Atanu Ghorai, et al.
Nuclear Medicine Communications|June 2, 2021
Prognostic significance of 18F-FDG PET/CT parameters in IDH-1 wild-type GBM and correlation with molecular markersIndraja Devidas Dev, Ameya D Puranik, Nilendu C Purandare, et al.
World Journal of Nuclear Medicine|September 14, 2019
Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging featuresAmeya D Puranik, Mathew Boon, Nilendu Purandare, et al.
Leukemia & Lymphoma|November 28, 2019
Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from IndiaKalasekhar Vijayasekharan, Maya Prasad, Nirmalya D Pradhan, et al.
American Journal of Blood Research|November 29, 2023
Intracranial disease in pediatric Hodgkin lymphoma-case report and review of literatureNidhi Dhariwal, Nirmalya Roy Moulik, Vasudeva Bhat, et al.
Oncoscience|June 23, 2015
MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1Kedar Yogi, Epari Sridhar, Naina Goel, et al.
Human Molecular Genetics|July 18, 2021
MiR-592 activates the mTOR kinase, ERK1/ERK2 kinase signaling and imparts neuronal differentiation signature characteristic of Group 4 medulloblastomaRaikamal Paul, Purna Bapat, Akash Deogharkar, et al.
The Neuroradiology Journal|January 6, 2026
Patterns of radiation-induced subependymal enhancement in patients with high-grade gliomaArpita Sahu, Daksh Mehta, Archya Dasgupta, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2022
Long-Term Clinical Outcomes and Sequelae of Therapy in Early-Stage Orbital Mucosa-Associated Lymphoid Tissue LymphomaGoutam Panda, Babusha Kalra, Anupam Rishi, et al.
Pediatric Blood & Cancer|September 1, 2020
Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in IndiaShyam Srinivasan, Nirmalya Roy Moulik, Anand Kc, et al.
Pageof 7